Botox
Botox is an originator product from AbbVie AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 235.80 to CHF 455.15 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- AbbVie AG
- ATC code
- M03AX01
- IT group
- 01.13 Myorelaxantia
- Active substances
- Toxinum botulinicum A
- Preparation type
- Originator product
- On the SL since
- 15/03/1997
- Last price change
- 01/12/2024
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Trockensub 50 E | Amp 2 Stk | CHF 201.70 | CHF 235.80 | 01/06/2022 | A | 7680524330024 |
| Trockensub 100 E | Amp 1 Stk | CHF 201.70 | CHF 235.80 | 15/03/1997 | A | 7680524330109 |
| Trockensub 100 E | 2 Amp 1 Stk | CHF 403.40 | CHF 455.15 | 01/12/2013 | A | 7680524330017 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Fokale Spastizität der oberen und unteren Extremität (inkl. Spitzfuss-Stellung) bei Jugendlichen und Kindern ab 2 Jahren (max. 4 Behandlungen pro Jahr).
Blepharospasmus, Spasmus hemifacialis, Strabismus, Torticollis spasticus.
Nach Ausschöpfung konservativer Therapieoptionen an einer in Neuro-Urologie oder Urogynäkologie spezialisierten Institution:
• Behandlung der Harninkontinenz infolge neurogener Detrusorhyperaktivität in Zusammenhang mit einer neurologischen Erkrankung (wie z.B. Rückenmarksverletzung, Multiple Sklerose) bei Erwachsenen.
• Behandlung der überaktiven Blase mit den Symptomen Harninkontinenz, Harndrang und häufige Miktion bei erwachsenen Patienten.
More preparations in this group
FAQ
Is Botox covered by Swiss health insurance?
Yes, but only under conditions. Botox is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Botox cost in Switzerland?
The public price is the maximum price set by the FOPH and for Botox ranges from CHF 235.80 to CHF 455.15 per pack. The ex-factory price ranges from CHF 201.70 to CHF 403.40. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages